CDC supports two funding opportunities that include perinatal HBV activities:
The goal of this funding opportunity is to facilitate or enhance the success of immunization practices to prevent mother-to-child transmission of hepatitis B.
- Improving identification of hepatitis B-infected pregnant women for the Perinatal Hepatitis B Prevention Program case management and prophylaxis of their infants
- Increasing the proportion of case-managed infants born to hepatitis B-infected women receiving postvaccination serologic testing
- Collecting demographic and clinical data, including data regarding maternal antiviral therapy, for ascertainment of factors associated with perinatal hepatitis B transmission and vaccine response
CDC’s NCIRD Perinatal Hepatitis B Prevention Program: CDC’s National Center for Immunization and Respiratory Diseases funds 64 U.S. jurisdictions to reduce mother-to-child transmission of hepatitis B virus infection by case-management of infants for :